Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS
Home/Press releases/Alterity Therapeutics Ltd

Press release

DATE OF AGM AND CLOSING DATE FOR DIRECTOR NOMINATIONS

Alterity Therapeutics LtdATHE · NASDAQPRNAF · OTC

Sep 25, 2026, 6:02 AM EDT

Share

logo.jpg

25 September 2026

ASX Announcement

Alterity Therapeutics Limited (ASX:ATH, NASDAQ:ATHE) (Alterity or the Company) advises that, in accordance with ASX Listing Rule 3.13.1, its next Annual General Meeting (AGM) will be held at 11.00am (AEDT) on Friday 20 November 2026.

In addition, the closing date for the receipt of nominations from persons wishing to be considered for election as a director is Friday 2 October 2026. Any nominations must be received in writing no later than 5.00pm (AEST) on Friday 2 October 2026 at the Company’s registered office.

Shareholders will be advised of further details regarding the AGM in a separate Notice of Meeting, which will be provided to shareholders shortly.  The Notice of Meeting will also be available on the ASX Company Announcements Platform and the Company’s website at www.alteritytx.com.

For further information, please contact:

image01.jpg

Abby Macnish Niven

CFO & Company Secretary

T:            +61 3 9349 4906

E:            cfo@alteritytx.com

Alterity Therapeutics Limited

Level 15, 500 Collins Street, Melbourne, VIC 3000 Australia

T: +61 (0)3 9349 4906 | www.alteritytx.com

Source: Alterity Therapeutics Ltd. This release was filed with the U.S. Securities and Exchange Commission on Sep 25, 2026 and is reproduced here as issued. View the filing.

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.